Byron S. Kalogerou

Featured in: Favicon

jdsupra.com Favicon

natlawreview.com Favicon

mondaq.com Favicon

mpo-mag.com Favicon

businesslawtoday.org

Articles

Weight-Loss, Alzheimer Drugs Drive M&A Market in Life Sciences

2 weeks ago | news.bloombergtax.com | Byron S. Kalogerou |Meredith Schwartz

Two years of instability within the mergers and acquisitions market has led to some beneficial lessons for the pharmaceutical industry. More companies are focused on spurring organic innovation with a focus on strategic partnerships with companies that will build lasting relationships over typical acquisitions. Despite the decrease in deal values in the past year, many in the life sciences industry are projecting a turnaround in growth.
Key Takeaways | State of the Market – Still Looking for an Exit | JD Supra

Dec 4, 2024 | jdsupra.com | Byron S. Kalogerou

During this session, the panelists discussed notable developments within the life sciences industry with a specific focus on the GLP-1 drug market and its opportunities for improvement in patient satisfaction and dosage. They also focused on recent increased deal activity and creativity within the MedTech industry while monitoring mid-tier deals in other areas of biopharma.
Key Takeaways | Outcome Of The 2024 Election And State Of The Market

Dec 4, 2024 | mondaq.com | Byron S. Kalogerou

MW McDermott Will & Emery More McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. With more than 1,100 lawyers across several office locations worldwide, our team works seamlessly across practices, industries and geographies to deliver highly effective solutions that propel success.
McDermott Will & Emery

Aug 6, 2024 | natlawreview.com | H. Byrne |Byron S. Kalogerou |Emily Cook |Bryan Frederick

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. With 20 locations on three continents, our team works seamlessly across practices, industries and geographies to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
[Event] Life Sciences Dealmaking Symposium - November 9th, Boston, MA | JD Supra

Oct 23, 2023 | jdsupra.com | Byron S. Kalogerou |John Karasek |Brian Bunn

Please join McDermott for our highly anticipated Life Sciences Dealmaking Symposium! Now in its 12th year, the Symposium offers a unique platform for education, insight sharing, purposeful networking and strategic collaboration. Why Attend? Discover actionable, in-depth programming curated by industry professionals, brought to you by the leading life sciences law firm. Gain invaluable insights into the most pressing transactional trends and developments shaping the life sciences deal market.
Reimagining the Business of Professional Golf: A Business Drama in Multiple Acts

Jul 18, 2023 | businesslawtoday.org | Dennis White |Byron S. Kalogerou

Steeped in tradition, governed by highly detailed rules of play, and with a culture that values sportsmanship and civility, professional golf had seemed for many years impervious to change. That state of quietude abruptly ended last year. What follows is an overview of the game-changing events that have recently occurred, the questions that remain unanswered, and anticipated next steps that will shape the final form that the business of golf will take.